ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
书/著作

Metabolomics applications in coronary artery disease personalized medicine

Amin, Arwa M.*
2021DOI: 10.1016/bs.acc.2020.08.003
10被引3阅读
引用收藏
分享

摘要

Coronary artery disease (CAD), the most common cardiovascular disease (CVD), contributes to significant mortality worldwide. CAD is a multifactorial disease wherein various factors contribute to its pathogenesis often complicating management. Biomarker based personalized medicine may provide a more effective way to individualize therapy in multifactorial diseases in general and CAD specifically. Systems' biology "Omics" biomarkers have been investigated for this purpose. These biomarkers provide a more comprehensive understanding on pathophysiology of the disease process and can help in identifying new therapeutic targets and tailoring therapy to achieve optimum outcome. Metabolomics biomarkers usually reflect genetic and non-genetic factors involved in the phenotype. Metabolomics analysis may provide better understanding of the disease pathogenesis and drug response variation. This will help in guiding therapy, particularly for multifactorial diseases such as CAD. In this chapter, advances in metabolomics analysis and its role in personalized medicine will be reviewed with comprehensive focus on CAD. Assessment of risk, diagnosis, complications, drug response and nutritional therapy will be discussed. Together, this chapter will review the current application of metabolomics in CAD management and highlight areas that warrant further investigation.

学科与关键词

关键词
INCIDENT CARDIOVASCULAR-DISEASEASSOCIATION TASK-FORCEMEDITERRANEAN DIETMITOCHONDRIAL DYSFUNCTIONFUNCTIONAL GENOMICSAMERICAN-COLLEGESOCIAL DRINKERSSYSTEMS BIOLOGYBLOOD-PRESSUREHEART-DISEASE
相关
加载中…
  • Metabolomics in early detection and prognosis of acute coronary syndrome
    Amiri, Mohammad Pouralijan; Khoshkam, Maryam; Salek, Reza M.*; Madadi, Reza; Ganji, Ghassem Faghanzadeh; Ramazani, Ali*Clinica Chimica Acta, 2019, 495: 43-53.被引 31
  • Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression
    Chen, Hui; Wang, Zixian; Qin, Min; Zhang, Bin; Lin, Lu; Ma, Qilin; Liu, Chen; Chen, Xiaoping; Li, Hanping; Lai, Weihua; Zhong, Shilong*Frontiers in Molecular Biosciences, 2021, 8: 632950.被引 14
  • Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease
    Zhu, Qian; Qin, Min; Wang, Zixian; Wu, Yonglin; Chen, Xiaoping; Liu, Chen; Ma, Qilin; Liu, Yibin; Lai, Weihua; Chen, Hui; Cai, Jingjing; Liu, Yemao; Lei, Fang; Zhang, Bin; Zhang, Shuyao; He, Guodong; Li, Hanping; Zhang, Mingliang; Zheng, Hui; Chen, Jiyan; Huang, Min; Zhong, Shilong*Cell and Bioscience, 2022, 12(1): 173.被引 3
查看全部 →

出版信息

丛书名称
Advances in Clinical Chemistry
出版社
ELSEVIER ACADEMIC PRESS INC,525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
编者
Makowski, GS
页数/页码
233-270
出版日期
2021
语种
Foreign Language

作者

  • A

    Amin, Arwa M. (通讯) (第一作者)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417